Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONEN
  Dieser Datensatz wurde verworfen!DetailsÜbersicht

Verworfen

Zeitschriftenartikel

X−ray damage to the Mn4Ca complex in single crystals of photosystem II: A case study for metalloprotein crystallography

MPG-Autoren
/persons/resource/persons93731

Kern,  Jana
Structure of neocortical circuits, Max Planck Institute for Medical Research, Max Planck Society;
Department of Biomedical Optics, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons94115

Loll,  Bernhard
Department of Biomolecular Mechanisms, Max Planck Institute for Medical Research, Max Planck Society;

Externe Ressourcen
Es sind keine externen Ressourcen hinterlegt
Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte in PuRe verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Yano, J., Kern, J., Irrgang, K., Latimer, M. J., Bergmann, U., Glatzel, P., et al. (2005). X−ray damage to the Mn4Ca complex in single crystals of photosystem II: A case study for metalloprotein crystallography. Proceedings of the National Academy of Sciences of the USA, 102(34), 12047-12052. doi:10.1073/pnas.0505207102.


Zusammenfassung
X−ray absorption spectroscopy was used to measure the damage caused by exposure to x−rays to the Mn4Ca active site in single crystals of photosystem II as a function of dose and energy of x−rays, temperature, and time. These studies reveal that the conditions used for structure determination by x−ray crystallography cause serious damage specifically to the metal−site structure. The x−ray absorption spectra show that the structure changes from one that is characteristic of a high−valent Mn4(III2,IV2) oxo−bridged Mn4Ca cluster to that of Mn(II) in aqueous solution. This damage to the metal site occurs at a dose that is more than one order of magnitude lower than the dose that results in loss of diffractivity and is commonly considered safe for protein crystallography. These results establish quantitative x−ray dose parameters that are applicable to redox−active metalloproteins. This case study shows that a careful evaluation of the structural intactness of the active site(s) by spectroscopic techniques can validate structures derived from crystallography and that it can be a valuable complementary method before structure−function correlations of metalloproteins can be made on the basis of high−resolution x−ray crystal structures